2Case JP. Old and new drugs used in rheumatoid arthritis: a historical perspective (Part 1): the older drugs. Am J Ther, 2001,8: 123～143. 被引量：1
3叶益新 张江林 黄烽.柳氮磺吡啶[A].见:蒋明 David Yu 林孝义 主编.中华风湿病学[C].北京:华夏出版社,2004.1746-1754. 被引量：2
4Cronstein BN. Therapeutic cocktails for rheumatoid arthritis: the mixmaster's guide. Arthritis Rheum, 2004, 50: 2041-2043. 被引量：1
5Jansen G, van der Heijden J, Oerlemans R, et al. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.Arthritis Rheum, 2004, 50: 2130-2139. 被引量：1
6Jansen G, Scheper R J, Dijkmans BA. Multidrug resistance proteins in rheumatoid arthritis, role in disease-modifying antirheumatic drug efficacy and inflammatory processes: an overview.Scand J Rheumatol, 2003, 32: 325-336. 被引量：1
7O'Dell JR, Leff R, Paulsen G, et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a 2-year, randomized, double blind, placebo-controlled trial. Arthritis Rheum, 2002, 46: 1164-1170. 被引量：1
8Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum, 2002,46: 347-356. 被引量：1
9Van der Heijden J, de Jong MC, Dijkmans B, et al. Development of sulfasalazine resistance in human T cells induced expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNF-α. Ann Rheum Dis, 2004, 63: 138-143. 被引量：1
10Van der Heijden J, de Jong MC, Dijkmans B, et al. Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARD. Ann Rheum Dis, 2004,63:131-137. 被引量：1
